UA100390C2 - Pyrrolo[2,3-d]pyrimidin derivatives as protein kinase b inhibitors - Google Patents

Pyrrolo[2,3-d]pyrimidin derivatives as protein kinase b inhibitors

Info

Publication number
UA100390C2
UA100390C2 UAA201005507A UAA201005507A UA100390C2 UA 100390 C2 UA100390 C2 UA 100390C2 UA A201005507 A UAA201005507 A UA A201005507A UA A201005507 A UAA201005507 A UA A201005507A UA 100390 C2 UA100390 C2 UA 100390C2
Authority
UA
Ukraine
Prior art keywords
protein kinase
pyrrolo
inhibitors
compounds
pyrimidin derivatives
Prior art date
Application number
UAA201005507A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Paul David Johnson
Andrew Leach
Richard William Arthur Luke
Zbigniew Stanley Matusiak
Jeffrey James Morris
Original Assignee
Астразенека Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Астразенека Аб filed Critical Астразенека Аб
Publication of UA100390C2 publication Critical patent/UA100390C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The invention relates to a novel group of compounds of Formula (1) or salts thereof: wherein Y, Z, Z, R, R, Rand n are as described in the specification, which may be useful in the treatment or prevention of a disease or medical condition mediated through protein kinase В (PKB) such as cancer. The invention also relates to pharmaceutical compositions comprising said compounds, methods of treatment of diseases mediated by PKB using said compounds and methods for preparing compounds of Formula (I).
UAA201005507A 2007-10-11 2008-10-09 Pyrrolo[2,3-d]pyrimidin derivatives as protein kinase b inhibitors UA100390C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US97919207P 2007-10-11 2007-10-11

Publications (1)

Publication Number Publication Date
UA100390C2 true UA100390C2 (en) 2012-12-25

Family

ID=50844211

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201005507A UA100390C2 (en) 2007-10-11 2008-10-09 Pyrrolo[2,3-d]pyrimidin derivatives as protein kinase b inhibitors

Country Status (2)

Country Link
AR (1) AR110013A2 (en)
UA (1) UA100390C2 (en)

Also Published As

Publication number Publication date
AR110013A2 (en) 2019-02-13

Similar Documents

Publication Publication Date Title
MX2010003927A (en) Pyrrolo [2, 3 -d] pyrimidin derivatives as protein kinase b inhibitors.
HK1157337A1 (en)
UA101611C2 (en) Compounds of imidazo[1,2-a]pyridine as receptor tyrosine kinase inhibitors
WO2009007749A3 (en) Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases
TN2011000263A1 (en) Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
WO2009071480A3 (en) Substituted dihydropteridin-6-one derivatives, process for their preparation and their use as kinase inhibitors
HK1136292A1 (en) Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
EA201000092A1 (en) TRIPLE-SUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES
UA99141C2 (en) Substituted indazole derivatives active as kinase inhibitors
EA201000090A1 (en) Triple substituted derivatives of pyrimidine for the treatment of proliferative diseases
WO2006067445A3 (en) Csf-1r kinase inhibitors
MX2009008953A (en) Spiro substituted compounds as angiogenesis inhibitors.
MX2009009843A (en) Spiro substituted compounds as angiogenesis inhibitors.
MY143565A (en) Novel fluorocglycoside derivatives of pyrazoles: medicaments containing these compounds, and the use thereof
EA201000091A1 (en) DERIVATIVES OF MORFOLINOPYRIMIDINE USED IN DISEASES ASSOCIATED WITH mTOR KINASE AND / OR PI3K
EA201000615A1 (en) IMIDAZO [1,2-A] PYRIDINE DERIVATIVES APPLICABLE AS APC INHIBITORS (ACTIVIN-like KINASE)
MX2009006401A (en) Indazole derivatives as kinase inhibitors for the treatment of cancer.
AU2009282962A8 (en) Compounds as kinase inhibitors
MX2011012337A (en) Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases.
TN2010000040A1 (en) 2-3-7-substituted imidazo - [1-2b] pyridazines for treatment of alk 4 or alk 5 mediated diseases
TW200724537A (en) Pyrimidine derivatives for treatment of hyperproliferative disorders
EA201001687A1 (en) IMIDAZOPIRIDINE DERIVATIVES AS AN INHIBITOR ACTIVATIVE-LIKE RECEPTOR KINASE (ALK-4 OR ALK-5)
MX2008013212A (en) 4-anilinoquinoline-3-carboxamides as csf-1r kinase inhibitors.
MX2010006748A (en) PYRAZOLO [1,5-a] PYRIMIDINES USEFUL AS JAK2 INHIBITORS.
MX336332B (en) Kinase inhibitors, prodrug forms thereof and their use in therapy.